Rapamycin regulates bleomycin-induced lung damage in SP-C-deficient mice

Pulmonary Medicine

Volumn , Issue , 2011, Pages

  Madala, Satish K ^a   Maxfield, Melissa D ^a   Davidson, Cynthia R ^a   Schmidt, Stephanie M ^a   Garry, Daniel ^a   Ikegami, MacHiko ^a   Hardie, William D ^a   Glasser, Stephan W ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYTOKINE; GAMMA INTERFERON; RAPAMYCIN; SURFACTANT PROTEIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FIBROSING ALVEOLITIS; GENE TARGETING; INTERFERON PRODUCTION; INTERSTITIAL LUNG DISEASE; LUNG COMPLIANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SURVIVAL; TH2 CELL; WEIGHT REDUCTION;

EID: 84857725925     PISSN: 20901836     EISSN: 20901844     Source Type: Journal    
DOI: 10.1155/2011/653524     Document Type: Article

References (38)

1. Cook D. N., Brass D. M., Schwartz D. A., A matrix for new ideas in pulmonary fibrosis American Journal of Respiratory Cell and Molecular Biology 2002 27 2 122 124 (Pubitemid 34780790)
2. Olson A. L., Swigris J. J., Lezotte D. C., Norris J. M., Wilson C. G., Brown K. K., Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003 American Journal of Respiratory and Critical Care Medicine 2007 176 3 277 284 (Pubitemid 47195878)
3. Whitsett J. A., Weaver T. E., Hydrophobic surfactant proteins in lung function and disease New England Journal of Medicine 2002 347 26 2141 2148 (Pubitemid 36015127)
4. Nogee L. M., Dunbar A. E., Wert S. E., Askin F., Hamvas A., Whitsett J. A., A mutation in the surfactant protein C gene associated with familial interstitial lung disease The New England Journal of Medicine 2001 344 8 573 579 (Pubitemid 32167871)
5. Wert S. E., Whitsett J. A., Nogee L. M., Genetic disorders of surfactant dysfunction Pediatric and Developmental Pathology 2009 12 4 253 274
6. Whitsett J. A., Wert S. E., Weaver T. E., Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease Annual Review of Medicine 2010 61 105 119
7. Thomas A. Q., Lane K., Phillips J., Prince M., Markin C., Speer M., Schwartz D. A., Gaddipati R., Marney A., Johnson J., Roberts R., Haines J., Stahlman M., Loyd J. E., Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred American Journal of Respiratory and Critical Care Medicine 2002 165 9 1322 1328 (Pubitemid 34461748)
8. Glasser S. W., Detmer E. A., Ikegami M., Na C. L., Stahlman M. T., Whitsett J. A., Pneumonitis and emphysema in sp-C gene targeted mice Journal of Biological Chemistry 2003 278 16 14291 14298 (Pubitemid 36799978)
9. Hartford C. M., Ratain M. J., Rapamycin: something old, something new, sometimes borrowed and now renewed Clinical Pharmacology and Therapeutics 2007 82 4 381 388 (Pubitemid 47414349)
10. Tee A. R., Blenis J., mTOR, translational control and human disease Seminars in Cell and Developmental Biology 2005 16 1 29 37 (Pubitemid 40126874)
11. Hardie W. D., Le Cras T. D., Jiang K., Tichelaar J. W., Azhar M., Korfhagen T. R., Conditional expression of transforming growth factor- in adult mouse lung causes pulmonary fibrosis American Journal of Physiology 2004 286 4 L741 L749
12. Hardie W. D., Davidson C., Ikegami M., Leikauf G. D., Le Cras T. D., Prestridge A., Whitsett J. A., Korfhagen T. R., EGF receptor tyrosine kinase inhibitors diminish transforming growth factor- -induced pulmonary fibrosis American Journal of Physiology 2008 294 6 L1217 L1225
13. Hardie W. D., Korfhagen T. R., Sartor M. A., Prestridge A., Medvedovic M., Le Cras T. D., Ikegami M., Wesselkamper S. C., Davidson C., Dietsch M., Nichols W., Whitsett J. A., Leikauf G. D., Genomic profile of matrix and vasculature remodeling in TGF- -induced pulmonary fibrosis American Journal of Respiratory Cell and Molecular Biology 2007 37 3 309 321 (Pubitemid 350067610)
14. Korfhagen T. R., Le Cras T. D., Davidson C. R., Schmidt S. M., Ikegami M., Whitsett J. A., Hardie W. D., Rapamycin prevents transforming growth factor- -induced pulmonary fibrosis American Journal of Respiratory Cell and Molecular Biology 2009 41 5 562 572
15. Lloberas N., Cruzado J. M., Franquesa M., Herrero-Fresneda I., Torras J., Alperovich G., Rama I., Vidal A., Griny J. M., Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats Journal of the American Society of Nephrology 2006 17 5 1395 1404 (Pubitemid 43673420)
16. Wu M. J., Wen M. C., Chiu Y. T., Chiou Y. Y., Shu K. H., Tang M. J., Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis Kidney International 2006 69 11 2029 2036
17. Krmer S., Wang-Rosenke Y., Scholl V., Binder E., Loof T., Khadzhynov D., Kawachi H., Shimizu F., Diekmann F., Budde K., Neumayer H. H., Peters H., Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat American Journal of Physiology 2008 294 2 F440 F449
18. Neef M., Ledermann M., Saegesser H., Schneider V., Reichen J., Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis Journal of Hepatology 2006 45 6 786 796 (Pubitemid 44646687)
19. Thannickal V. J., Roman J., Challenges in translating preclinical studies to effective drug therapies in idiopathic pulmonary fibrosis American Journal of Respiratory and Critical Care Medicine 2010 181 6 532 533
20. Moore B. B., Hogaboam C. M., Murine models of pulmonary fibrosis American Journal of Physiology 2008 294 2 L152 L160
21. Wills-Karp M., Luyimbazi J., Xu X., Schofield B., Neben T. Y., Karp C. L., Donaldson D. D., Interleukin-13: central mediator of allergic asthma Science 1998 282 5397 2258 2261 (Pubitemid 29004074)
22. Amin R. S., Wert S. E., Baughman R. P., Tomashefski J. F., Nogee L. M., Brody A. S., Hull W. M., Whitsett J. A., Surfactant protein deficiency in familial interstitial lung disease Journal of Pediatrics 2001 139 1 85 92 (Pubitemid 32613992)
23. Tredano M., Griese M., Brasch F., Schumacher S., De Blic J., Marque S., Houdayer C., Elion J., Couderc R., Bahuau M., Mutation of SFTPC in infantile pulmonary alveolar proteinosis with or without fibrosing lung disease American Journal of Medical Genetics 2004 126 1 18 26 (Pubitemid 38443349)
24. Glasser S. W., Witt T. L., Senft A. P., Baatz J. E., Folger D., Maxfield M. D., Akinbi H. T., Newton D. A., Prows D. R., Korfhagen T. R., Surfactant protein C-deficient mice are susceptible to respiratory syncytial virus infection American Journal of Physiology 2009 297 1 L64 L72
25. Lawson W. E., Polosukhin V. V., Stathopoulos G. T., Zoia O., Han W., Lane K. B., Li BO., Donnelly E. F., Holburn G. E., Lewis K. G., Collins R. D., Hull W. M., Glasser S. W., Whitsett J. A., Blackwell T. S., Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycin American Journal of Pathology 2005 167 5 1267 1277 (Pubitemid 41541413)
26. Simler N. R., Howell D. C. J., Marshall R. P., Goldsack N. R., Hasleton P. S., Laurent G. J., Chambers R. C., Egan J. J., The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats European Respiratory Journal 2002 19 6 1124 1127 (Pubitemid 34649629)
27. Mehrad B., Burdick M. D., Strieter R. M., Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis International Journal of Biochemistry and Cell Biology 2009 41 8-9 1708 1718
28. Kaminski N., Allard J. D., Pittet J. F., Zuo F., Griffiths M. J. D., Morris D., Huang X., Sheppard D., Heller R. A., Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis Proceedings of the National Academy of Sciences of the United States of America 2000 97 4 1778 1783 (Pubitemid 30118519)
29. Buschhausen L., Kamm M., Arns W., Schulze-Lohoff E., Weber M., Successful treatment of a severe case of idiopathic pulmonary fibrosis with rapamycinErfolgreiche rapamycin-therapie bei idiopathischer pulmonaler fibrose (IPF) im prfinalstadium Medizinische Klinik 2005 100 3 161 164 (Pubitemid 40521580)
30. Foley J. E., Jung U., Miera A., Borenstein T., Mariotti J., Eckhaus M., Bierer B. E., Fowler D. H., Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism Journal of Immunology 2005 175 9 5732 5743 (Pubitemid 41508056)
31. Fichtner-Feigl S., Strober W., Kawakami K., Puri R. K., Kitani A., IL-13 signaling through the IL-13 receptor is involved in induction of TGF- production and fibrosis Nature Medicine 2006 12 1 99 106 (Pubitemid 43050083)
32. Glasser S. W., Senft A. P., Whitsett J. A., Maxfield M. D., Ross G. F., Richardson T. R., Prows D. R., Xu Y., Korfhagen T. R., Macrophage dysfunction and susceptibility to pulmonary Pseudomonas aeruginosa infection in surfactant protein C-deficient mice Journal of Immunology 2008 181 1 621 628
33. Champion L., Stern M., Isral-Biet D., Mamzer-Bruneel M. F., Peraldi M. N., Kreis H., Porcher R., Morelon E., Brief communication: sirolimus-associated pneumonitis: 24 Cases in renal transplant recipients Annals of Internal Medicine 2006 144 7 505 509 (Pubitemid 46780673)
34. Feagans J., Victor D., Moehlen M., Florman S. S., Regenstein F., Balart L. A., Joshi S., Killackey M. T., Slakey D. P., Paramesh A. S., Interstitial pneumonitis in the transplant patient: consider sirolimus-associated pulmonary toxicity The Journal of the Louisiana State Medical Society 2009 161 3 166 172
35. Vandewiele B., Vandecasteele S. J., Vanwalleghem L., De Vriese A. S., Diffuse alveolar hemorrhage induced by everolimus Chest 2010 137 2 456 459
36. White D. A., Camus P., Endo M., Escudier B., Calvo E., Akaza H., Uemura H., Kpamegan E., Kay A., Robson M., Ravaud A., Motzer R. J., Noninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma American Journal of Respiratory and Critical Care Medicine 2010 182 3 396 403
37. Letavernier E., Bruneval P., Vandermeersch S., Perez J., Mandet C., Belair M. F., Haymann J. P., Legendre C., Baud L., Sirolimus interacts with pathways essential for podocyte integrity Nephrology Dialysis Transplantation 2009 24 2 630 638
38. Merrill J. D., Ballard R. A., Cnaan A., Hibbs A. M., Godinez R. I., Godinez M. H., Truog W. E., Ballard P. L., Dysfunction of pulmonary surfactant in chronically ventilated premature infants Pediatric Research 2004 56 6 918 926 (Pubitemid 39552774)